Pacific Radiance Future Growth

Future criteria checks 2/6

Pacific Radiance's earnings are forecast to decline at 80.7% per annum while its annual revenue is expected to grow at 21% per year. EPS is expected to decline by 42.4% per annum. Return on equity is forecast to be 5.4% in 3 years.

Key information

-80.7%

Earnings growth rate

-42.4%

EPS growth rate

Energy Services earnings growth14.2%
Revenue growth rate21.0%
Future return on equity5.4%
Analyst coverage

Low

Last updated11 Dec 2024

Recent future growth updates

No updates

Recent updates

Investors Appear Satisfied With Pacific Radiance Ltd.'s (SGX:RXS) Prospects As Shares Rocket 33%

Oct 09
Investors Appear Satisfied With Pacific Radiance Ltd.'s (SGX:RXS) Prospects As Shares Rocket 33%

Why Investors Shouldn't Be Surprised By Pacific Radiance Ltd.'s (SGX:RXS) 29% Share Price Surge

Aug 13
Why Investors Shouldn't Be Surprised By Pacific Radiance Ltd.'s (SGX:RXS) 29% Share Price Surge

Pacific Radiance Ltd. (SGX:RXS) Stock's 31% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Jun 03
Pacific Radiance Ltd. (SGX:RXS) Stock's 31% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Pacific Radiance's (SGX:RXS) Weak Earnings Might Be Worse Than They Appear

Apr 22
Pacific Radiance's (SGX:RXS) Weak Earnings Might Be Worse Than They Appear

Even With A 30% Surge, Cautious Investors Are Not Rewarding Pacific Radiance Ltd.'s (SGX:RXS) Performance Completely

Mar 11
Even With A 30% Surge, Cautious Investors Are Not Rewarding Pacific Radiance Ltd.'s (SGX:RXS) Performance Completely

Investors Don't See Light At End Of Pacific Radiance Ltd.'s (SGX:RXS) Tunnel And Push Stock Down 27%

Nov 27
Investors Don't See Light At End Of Pacific Radiance Ltd.'s (SGX:RXS) Tunnel And Push Stock Down 27%

Why Pacific Radiance's (SGX:RXS) Healthy Earnings Aren’t As Good As They Seem

Nov 21
Why Pacific Radiance's (SGX:RXS) Healthy Earnings Aren’t As Good As They Seem

Earnings and Revenue Growth Forecasts

SGX:RXS - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20265639131
12/31/202556511102
12/31/20244317-8142
6/30/20243427221N/A
3/31/20243320-210N/A
12/31/2023311549N/A
9/30/202332456N/A
6/30/2023313071111N/A
3/31/2023343071111N/A
12/31/20223032512N/A
9/30/20222432444N/A
6/30/20221916-4-4N/A
3/31/202212120-1N/A
12/31/202110166N/A
9/30/2021-33161110N/A
6/30/2021-18678N/A
3/31/2021-5189N/A
12/31/20209-667N/A
9/30/202071-7666N/A
6/30/202071-751111N/A
3/31/202076-7878N/A
12/31/201975-85-10N/A
9/30/201969-103-6-2N/A
6/30/201969-96-12-9N/A
3/31/201965-91-11-9N/A
12/31/201861-99-10-9N/A
9/30/201865-320-12-10N/A
6/30/201864-329-9-8N/A
3/31/201865-331N/A-16N/A
12/31/201768-333N/A-23N/A
9/30/201761-72N/A-32N/A
6/30/201763-77N/A-42N/A
3/31/201765-127N/A-43N/A
12/31/201669-119N/A-45N/A
9/30/201679-85N/A-53N/A
6/30/201694-65N/A-35N/A
3/31/2016109-5N/A-23N/A
12/31/20151224N/A19N/A
9/30/201513711N/A67N/A
6/30/201514823N/A68N/A
3/31/201516253N/A87N/A
12/31/201417268N/A62N/A
9/30/201417780N/A62N/A
6/30/201418277N/A34N/A
3/31/201417966N/A34N/A
12/31/201316957N/A29N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: RXS's earnings are forecast to decline over the next 3 years (-80.7% per year).

Earnings vs Market: RXS's earnings are forecast to decline over the next 3 years (-80.7% per year).

High Growth Earnings: RXS's earnings are forecast to decline over the next 3 years.

Revenue vs Market: RXS's revenue (21% per year) is forecast to grow faster than the SG market (3.7% per year).

High Growth Revenue: RXS's revenue (21% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: RXS's Return on Equity is forecast to be low in 3 years time (5.4%).


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 13:32
End of Day Share Price 2024/12/23 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pacific Radiance Ltd. is covered by 10 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Meghana KandeCGS International
Royston TanDaiwa Securities Co. Ltd.
Suvro SarkarDBS Bank Ltd